Study with two prokinetics in functional dyspepsia and gord: Domperidone vs. Cisapride

Journal of Physiology and Pharmacology

Volumn 48, Issue 2, 1997, Pages 185-192

  Halter, F ^a,e   Staub, P ^b   Hammer, B ^c   Guyot, J ^f   Miazza, B M ^d  

^a UNIVERSITY OF BERN   (Switzerland)

^b Cantonal Hospitals of Herisau   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d Ospedale Civico Lugano   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f NONE

Author keywords

Cisapride; Domperidone; Dyspepsia; Endoscopy; Functional; GORD; Therapeutic trial

Indexed keywords

CISAPRIDE; DOMPERIDONE; PROKINETIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-ULCER AGENTS; CISAPRIDE; DOMPERIDONE; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; TREATMENT OUTCOME;

EID: 0030874377     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Valenzuela JE, Dooley CP: Dopamine antagonists in the upper gastrointestinal tract. Scand J Gastroenterol. 1984; 20(?): 127-136.
2. Barone JA, Jessen LM, Colaizzi JL, Bierman RH. Cisapride: a gastrointestinal prokinetic drug. Ann Pharmacother 1994; 28 (4): 488-500.
3. Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone: A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24 (5): 360-400.
4. Van Outryve M, Lauwers W, Verbeke S. Domperidone for the symptomatic treatment of chronic postprandial nausea and vomiting. Postgrad Med J 1979; 55 (1): 33-35.
5. Agorastos I, Zissis NP, Kaprinis I, Goulis-G. Double-blind evaluation of domperidone in acute vomiting and dyspeptic disorders. J Int Med Res 1981; 9 (2): 143-147.
6. Haarmann K, Lebkuchner F, Widmann A, Kief W, Esslinger M. A double-blind study of domperidone in the symptomatic treatment of chronic postprandial upper gastrointestinal distress. Postgrad Med J 1979; 55 (1): 24-27.
7. Van Outryve M, De Nutte N, Van Eeghem P, Gooris JP. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramidc: a double-blind, placebo-controlled study. Scand J Gastroenterol 1993; Suppl 195: 47-52.
8. Heading RC. Definitions of dyspepsia. Scand J Gastroenterol 1991; 26, Suppl 182: 1-6.
9. Talley JN et al. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378-1386.
10. Rösch W. Chronic functional dyspepsia: short and medium-term outcome of a therapeutic trial with cisapride. Clin Ther 1994; 16 (3): 437-445.
11. Heyse PM, Rambaldo R, Hazelhoff B. Factors affecting short and long-term outcome of a short therapeutic trial with cisapride in dyspeptic patients. Scand J Gastroenterol 1993; Suppl. 195: 15-23.